Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

STAT gathered reactions from leaders across biotech and pharma about what the new Trump era could mean for them.

Despite significant medical advancements in the oncology space, 30% of patients in the GSK/Harris Poll survey said they never ...

The FDA updated GLP-1 drug labels to warn of the risk of patients breathing food into their lungs while under anesthesia for ...

The sale does not mean a complete exit from oncology for GSK – it will continue with programmes in immunotherapy, epigenetics, and tumour environment. The deal with Novartis includes the ...

THE ARM FOR THE LANCASTER COUNTY ECONOMY. THIS IS FOR GSK, THE LARGEST INVESTMENT IN MANUFACTURING WE’VE EVER DONE IN THE UNITED STATES. THE $800 MILLION WILL BE USED TO EXPAND GSK’S MARIETTA ...

This is a major concern for Moderna because it could mean that they used a GSK technology to produce their COVID-19 vaccine, Spikevax, as well as their RSV vaccine, mResvia. GSK asserts that ...

GSK is delivering consistent financial performance ... The Gardasil royalty loss impacted profit growth by minus 8% this quarter, meaning underlying operating profit was up 13%, demonstrating ...

GSK plc GSK announced positive data from the ... nasal polyp score at 52 weeks and the change from baseline in mean nasal obstruction score from weeks 49 to 52. Data from the studies showed ...

The trial’s co-primary endpoints were RSV-A and RSV-B neutralization titers following a first and a second dose of GSK’s RSV vaccine expressed as mean geometric increase post dose 2 relative ...

SUNNYVALE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and preventive health company, ...